The College says that until now, veterinary research has largely ignored lipomas because they are rarely referred for specialist treatment.
For the study, the RVC identified 2765 lipoma cases from a population of 384,284 dogs in its VetCompass Programme (which collects anonymised clinical data on dogs under primary veterinary care in the UK) in 2013.
The study found that 1 in 50 dogs are affected by lipomas each year and that Springer Spaniels, Dobermann Pinschers, Weimaraners and Labrador Retrievers are the most susceptible to lipomas (5-8% prevalence).
The study also found:
At least one lipoma was diagnosed in 1.94% of dogs during the single year of the study.
Individual dogs with an adult bodyweight that was equal or higher than their breed/sex average had 1.96 times the odds of lipoma.
As dogs age, their odds of getting lipoma increase. Dogs aged between 9-12 years were over 17 times more likely to be diagnosed with lipoma compared to dogs aged 3-6 years old.
Neutered dogs had higher risk.
Insured dogs had 1.78 times the odds of diagnosis.
Purebred dogs had 1.16 times the odds compared with crossbred dogs.
Dr Lynda Rutherford, Clinician and Lecturer in Small Animal Surgery at the RVC, said: "This paper has supported the theory that lipomas are more common in older, overweight dogs.
"This information is useful as it can be discussed with owners and used as another reason to keep pet dog’s weight under control. It also provides a useful insight into how common lipomas are within the UK dog population."
Reference
O'NEILL, D. G., CORAH, C. H., CHURCH, D. B., BRODBELT, D. C. & RUTHERFORD, L. 2018. Lipoma in dogs under primary veterinary care in the UK: prevalence and breed associations. Canine Genetics and Epidemiology, 5, 9. https://cgejournal.biomedcentral.com/articles/10.1186/s40575-018-0065-9
The company says it recognises how frustrating it can be for veterinary surgeons if the owner doesn't recognise that their dog has a painful condition. This can be compounded by short consult times, leaving vets unable to fully communicate the implications and treatment options for the disease.
In the video, Zoe encourages vets to tailor their language to each case, in particular, using the language dog owners will use.
While undertaking her research Zoe noticed that many owners do not talk about OA in the same way that vets might; instead of referring to lameness or pain, many owners will refer to the actual physical signs of OA such as stiffness or communicate that their dog is slowing down.
Zoe has also warned that not all owners are convinced by visual demonstrations such as flexing and extending the dogs joints. Instead, she suggests encouraging the owner to get hands-on.
Zoe said: "Point out the visual changes suggestive of osteoarthritis that you can see, such as muscle loss, scuffed nails, and enlarged joints. And encourage them to have a look and a feel, comparing affected and unaffected joints. Hopefully, the owner may be more receptive to the conversation now they associate it with a symptom they can recognise."
Zoe says she also finds that many owners of older dogs often misinterpret the signs of OA as 'just old age' and may not be aware that the condition can be managed effectively with medication, the right exercise, diet and by making modifications in the home.
Elanco has also produced an OA management template which enables both the vet and the owner to create a tailored plan. It provides the owner with information to take away with them about how to modify their home, written in collaboration with Founder of Canine Arthritis Management, Hannah Capon.
Lastly, Zoe recommends a whole practice approach to becoming experts on OA, veterinary nurses in particular. She said: "Vet nurses often have great ideas about how to explain the condition in a way that owners understand. Better owner understanding of OA should lead to better adherence to treatment plans and ultimately better clinical outcomes."
To watch the video, click here.
To access the suite of assets Elanco has created for Onsior (which includes the management plan, social media posts for the practice, and infographic to help owners to spot the signs of OA) visit: www.myelanco.co.uk
The UK has now seen a total of 169 confirmed cases of Alabama Rot across 38 counties, since 2012. Six cases were confirmed in 2012, climbing to 40 in 2017 and 46 so far in 2018.
The new research, which was carried out in conjunction with the Royal Veterinary College, found that almost 95% of confirmed cases of Alabama Rot have occurred between November and May, with the highest number of cases being reported in February.
It also found most of the cases have been confirmed in western and southern parts of England, with the highest number found in West Sussex, Dorset, southern Hampshire, Greater Manchester and Monmouthshire. Far fewer cases have been reported from the eastern half of the country and East Anglia in particular.
David Walker, Head of medicine at Anderson Moores and co-author of the research, said: "This research, which was funded by the New Forest Dog Owners Group and the charity Alabama Rot Research Fund, was designed to look for geographical patterns, as well as environmental and climatic risk factors.
"A distinct seasonal pattern is suggested, with the vast majority of cases occurring between November and March, and limited cases over the summer months – just 6.5% of cases have been confirmed from June to October.
"In the scientific world a lot of research is not earth-shattering, but it all builds together and little by little we make progress.
"This information is good in terms of how we manage the next stage of research, however we need to be careful and not jump to any conclusions at this point".
Researchers say the disease has been reported in a wide range of breeds (35 in total) but, due to the small number of cases, it is not yet possible to say with any certainty whether a specific breed has an inherently increased or decreased risk of the disease. Any patterns may simply be the result of varying breed populations in different parts of the country.
Dr Huw Stacey, vet and director of clinical services at Vets4Pets, has been supporting research on the condition for a number of years. He said: "Since we held the first Alabama Rot conference in May 2017, vets and relevant professionals have been working hard to understand more about the condition.
"We know how the disease presents and how it affects dogs internally, and this research adds some interesting information that may help to increase vets’ index of the suspicion for the disease.
"The information on climate and ground type will help us further explore possible triggers for the disease, but at the moment we can’t say if any breeds are more likely to develop the disease.
"The first sign of the disease that is normally seen is a skin sore or lesion that isn’t caused by a known injury. Most commonly these sores are found on the lower half of the leg and appear as a distinct swelling, a patch of red skin or are open and ulcer-like.
"With 46 cases in 2018 already, it is understandably very worrying for dog owners, but we think the increase in cases is partially due to an increased awareness of the disease.
"However, this disease is still very rare, so we’re advising dog owners to remain calm but vigilant, and seek advice from their local vet if their dog develops unexplained skin lesions.
"While this research may be a stepping stone to finding the cause of Alabama Rot, there is currently no known way to prevent a dog from contracting the disease."
*also clinically known as
This year the College is seeking nominations for six awards:
The Queen’s Medal: the highest honour that can be bestowed upon a veterinary surgeon for a highly distinguished career with sustained and outstanding achievements throughout.
The Veterinary Nursing Golden Jubilee Award: this award is aimed at veterinary nurses who have had a sustained and distinguished career, who can demonstrate a leadership role within the profession and who can act as an ambassador for the value of veterinary nurses and their work.
RCVS International Award: this award is for vets, vet nurses or laypeople who work internationally, from either within or outside the UK, in making an outstanding contribution to, for example, raising veterinary standards, veterinary education and improving animal health and welfare.
RCVS Impact Award: this award is for vets or vet nurses who have recently, or are currently, undertaking a project, initiative or similar that has a significant impact on the profession at large, animal health or welfare, or public health. Such impact could have been made through any field of veterinary endeavour, including clinical practice, research, education or veterinary politics.
RCVS Inspiration Award: this award is for vets or vet nurses at any stage of their career who have demonstrated the ability to inspire and enthuse others consistently throughout. It is open to those who have inspired and motivated individuals anywhere within the profession and recognises those who have gone ‘above and beyond’ what may normally be expected from a professional colleague.
Honorary Associateship: this honour is conferred to a small number of laypeople each year, in recognition of their special contribution to the veterinary sphere. It recognises the full range of individuals who contribute to the veterinary sphere including scientists, lecturers, journalists, charity-workers, farriers, farmers and those involved in the commercial field.
For this year’s honours and awards nomination period, the College has produced a video using footage from Royal College Day 2018, featuring interviews with those who were recognised with RCVS honours and awards on the day.
The video is available to view at www.rcvs.org.uk/honours where you can also download further information and guidance about the criteria for nominators and nominees for the awards, as well as how to make nomination.
Dr Niall Connell, RCVS Junior Vice-President, is taking the lead in promoting the awards this year. He said: "Throughout my time in the veterinary profession, and particularly since joining RCVS Council, I have met so many veterinary nurses and veterinary surgeons who are truly inspiring individuals.
"The RCVS honours and awards scheme is a perfect opportunity to celebrate some of the individuals that have done or are doing something really special – whether that’s by inspiring their colleagues and peers or doing things that benefit animal health and welfare or society at large.
"Across all six awards there really is something for everyone – vets and veterinary nurses at all stages of their careers as well as laypeople are all up for recognition and so I’d strongly encourage everyone to think about someone they know who deserves recognition and get in touch.”
The deadline for nominations is Friday 18 January 2019.
For an informal talk about the awards and how to make a nomination you can contact Peris Dean, Executive Secretary, on p.dean@rcvs.org.uk or 020 7202 0761.
Protexin says Pro-Kolin Advanced contains beneficial micro-organisms, several prebiotic sources, an optimal level of a dual-source binding agent and soothing fibres to support gastrointestinal function.
The company also says that in a study involving 148 dogs, Pro-Kolin Advanced significantly improved clinical outcome compared to a placebo1.
Protexin Veterinary Director, James Kyffin, said: "Pro-Kolin Advanced represents an exciting development for Protexin Veterinary and fits in perfectly with our ethos to produce innovative, research-based products of the highest quality for pets.
"It is the first product of its kind to be supported by a randomised, controlled clinical trial that was undertaken in first opinion veterinary practices across the UK and Ireland.
"Not only are we pleased to be able to offer veterinary surgeons with an evidence-based option for the management of acute gastrointestinal disturbances, but also a very palatable formulation that was readily accepted by 92% of the dogs in the study."
Pro-Kolin Advanced is available in 15ml, 30ml and 60ml syringes for dogs and 15ml syringes for cats. The flavourings used in the product contain no proteins or common allergens so Pro-Kolin Advanced can be used in animals with known hypersensitivities.
The trial, which was conducted by a UK-French team of researchers from PBD Biotech and Biosellal, is being presented at the European Association of Veterinary Laboratory Diagnosticians (EAVLD) Congress in Brussels today.
Current tests only allow the reliable detection of Mycobacterium avium subspecies paratuberculosis (MAP) from 18-24 month calves and are unable to distinguish between active and passive infection.
For the 16-month trial, calves from three different herds and born from MAP-positive and MAP-negative cows were tested monthly using PBD Biotech’s Actiphage Rapid kit and Biosellal’s Bio-T kit MAP PCR on blood samples, and the same PCR on faeces.
Researchers say the trial proves that early detection of live MAP infection is possible, and paves the way for improved Johne’s disease monitoring and control measures on farms.
Co-Author Dr Ben Swift, Research Fellow in Antimicrobial Resistance at the Royal Veterinary College and R&D Director at PBD Biotech, said: "Young animals are highly susceptible to infection and being able to identify Johne’s disease at this early stage is key to controlling disease spread.
The trial showed that the sensitivity and specificity of Actiphage enables detection of lower levels of MAP than the current culture methods, and provides results in 6 hours rather than weeks."
The Actiphage Rapid technology used in the trial identified live MAP infection at least 4 weeks’ earlier than the faecal PCR in 75% of cases: in one case, the new diagnostic detected MAP in the blood of a one-day old calf born from a MAP-positive cow.
Claire Pelletier, Directrice Générale of BioDev, consultant to Biosellal, will be presenting findings from the trial, which also showed the transient nature of the infection. She said: "The study showed that two calves, identified as MAP-positive by Actiphage-PCR on blood during the first monthly sampling didn’t shed MAP into their faeces until 10 and 11 months. This emphasises that early detection provides a short window of time that allow for control of the disease."
Other international trials using Actiphage are underway to investigate the presence of MAP in milk.
The company says that the 20 module medicine programme, covering all of the major body systems of cats and dog, combines the latest thinking in small animal medicine with its world-class learning resources to ensure that delegates’ learning experience online gives the same high-quality learning as the attendance programme.
Improve says it aims to offer a route for veterinary surgeons who don’t have the time to participate in an attendance programme or who work in countries where this type of training is not available, the opportunity to study for a recognised postgraduate qualification.
Delegates signing up for the programme will have a module tutor – an RCVS or ECVIM/ACVIM Small Animal Internal Medicine Diploma holder – and a dedicated programme tutor who works with individual delegates to ensure they are supported throughout the programme.
Improve says the course includes interactive and engaging modules, together with real-life case studies, presentations, written notes, interactive quizzes and exercises.
Dr Alison Babington MRCVS, Business Coordinator at Improve said: "The pressures on veterinary professionals today have never been more intense and many of us struggle to find the work-life balance which is so important for our well-being. Unfortunately, these pressures often preclude many vets from undertaking the type of postgraduate training which could give them additional job satisfaction and enhance both their career prospects and the profitability of their practice.
"It has been our ambition for some time to offer some of our flagship programmes online and, in creating the Distance Learning Small Animal Medicine programme, we drew on the experience of the latest online platforms.
"This new Distance Learning Programme offers a high quality interactive, engaging Small Animal Medicine learning experience which will be fun to study and a far cry from the days of simply reading text online. It will be accessible to vets working anywhere in the world and we’re very proud to be able to offer a high level programme via this learning route."
For more information visit: www.improveinternational.com or ring 01793 759159.
The practice's dentistry and oral surgery team, led by Peter Southerden, has now carried out its first two successful reconstructions using the technique, following oral tumour resection.
Use of patient-specific implants (PSI) for jaw reconstruction is a new technique, which provides an alternative to bone regenerative techniques. Both techniques can be used in cases which have had significant jaw resection or need reconstructive surgery after a trauma.
Peter said: "To my knowledge, using this technique to create patient-specific implants for rostral mandibular reconstruction following bilateral rostral mandibulectomy has not been reported in dogs before.
"The reconstructive surgery involves taking pre and post-operative CT scans of the affected area and sending them to a specialist human medical PSI design company, which then uses 3D titanium printing technology to recreate the missing bone.
"In our first two cases, both dogs are doing really well. The feedback we’ve received from owners suggests their dogs have gained significant benefit from the jaw reconstruction process."
Peter is one of three dentistry and oral surgery clinicians at Eastcott alongside Andrew Perry and resident Ingrid Tundo, with a second resident due to join in 2019.
The team caters for dentistry cases including periodontology, endodontics, orthodontics and restorative dentistry, to complex cases including oral tumours, traumatic injuries and congenital issues such as cleft palates.
Peter added: "There aren’t many people with specialist qualifications in this field, possibly only six in the UK and we are the only team working with the backup of a multi-disciplinary referral hospital.
"Having a team of three, soon to be four, is unusual and means we have a big caseload and see a wide range of different cases. We are very keen on developing new techniques such the ones we have already introduced."
For more information about Eastcott Referrals, visit www.eastcottreferrals.co.uk.
The original editorial team of Daniel Brockman and David Holt has been joined by Gert ter Haar to produce a new edition which considers the substantial progress that has been made in this important field, including the challenges of treating airway abnormalities linked to brachycephalism, the constraints of complex bony anatomy and rich vascularity of the head when performing radical surgery, and the treatment of trauma.
The book includes a number of new techniques, including dorsal rhinotomy and total ear canal ablation.
The BSAVA says operative techniques, instructive photographs and full-colour illustrations remain a key feature of the manual, which is aimed at the general veterinary practitioner.
The BSAVA Manual of Canine and Feline Head, Neck and Thoracic Surgery, 2nd edition is available from the BSAVA website: www.bsava.com or by phone: 01452 726700.
The company says it has redesigned the packaging to make it more distinctive, the idea being that it makes stock control in the practice and vaccine management on the farm easier and it also makes it easier for veterinary surgeons to identify and grab the right product off the shelf.
The new, bright red packaging for Bovilis IBR Marker Live is shown right. What do you think? Comment below.
Virtual Vet Derms has been set up to be able to give advice to veterinary surgeons on any aspect of skin or ear disease whether it is allergy, otitis media, cutaneous neoplasia or endocrine-based in any species, including dogs, cats, small furries, exotic pets including raptors, birds and reptiles, horses, camelids, zoo and farm animals.
Sue, herself an RCVS Recognised Specialist in Veterinary Dermatology, is supported by a team of veterinary dermatology colleagues as well as veterinary specialists in exotic medicine, internal medicine (including endocrinology) and consultants with expertise in oncology.
Sue said: "We recognise that not every veterinarian has got access to a local dermatology specialist and that not all clients can or want to travel to a referral centre. The aim of the service is to formalise the advice that dermatology clinicians give to veterinary surgeons to allow them to get detailed help to manage difficult or challenging dermatology cases within their own practice."
The service has been set up under the RCVS Vivet initiative, is approved by all of the major insurance companies and supported with Veterinary Defence Society Insurance cover.
Virtual Vet Derms offers support in a range of ways.
Quick questionsShort questions that veterinary surgeons can submit via the online form on the Virtual Vet Derms website that just require a brief reply. This may be a dose of a drug, a parasite you want identifying, or the interpretation of a blood sample such as an ACTH stimulation test.
Veterinary reportsVeterinary surgeons can use online request forms on the Virtual Vet Derms web site to submit a brief history of the animal and the problem and some good quality photos of the skin condition. There is also the ability to upload histopathology reports, blood samples and any other pertinent information. A detailed written report is sent back to the vet within 48 hours which will describe clinical signs, differential diagnoses, recommended diagnostic tests and treatment option where appropriate. Where possible, Virtual Vet Derms aims to pass the advice request to the nearest dermatologist but vets can ask for advice from any of its specialists.
Telemedicine consultationsFor new cases or for cases where initial advice has been sought, in the client's own primary care veterinary practice via the internet. The Virtual Vets Derms specialist can consult with the owner to provide even more specific advice and support. After each teleconsultation the Virtual Vet Derms specialist will produce a report in the same format as the veterinary report to allow the primary care veterinary surgeon to continue to manage the case more effectively.
Face to face consultationsCan also be arranged via the owner’s vet at the specialist's own practice if there is the need for more specialist investigation that may not be available in the primary care veterinary surgery. In these cases, the specialist will take on the direct care of the case and work with the owner and vet on the best course of action.
General advice Also possible if the vet wishes to direct an owner straight to Virtual Vet Derms.
For more information, visit: https://virtualvetderms.com
The Statutory Membership Examination must be taken by all individuals educated outside of the UK whose veterinary qualification is not recognised by the RCVS. Passing the exam allows them to join the UK Register, and practice as a veterinary surgeon in the UK.
The exam has existed in its current format for over 30 years, and the review was implemented to ensure the examination remains fit for purpose, and sits in line with international best-practice and the College’s current Day-one Competences.
The College says the review was also designed to make sure it is using the most appropriate means of assessment methods, to best prepare candidates for success, and to ensure candidates can work in the UK to the best of their ability.
The written examination will now consist of two parts; a clinical Multiple Choice Question (MCQ) paper (in a single best answer clinical vignette format) and an open book examination, which will be used to ascertain the candidate’s knowledge of the RCVS Code of Professional Conduct.
The Clinical, Practical Examination will now exist in the form of a multi-dimensional Objective Structured Clinical Examination (OSCE). This examination is set to measure a range of clinical, technical and professional skills including clinical reasoning, communication, professionalism, and ethical awareness. Following a tender process, Glasgow Veterinary School has been awarded the contract to host the OSCE examination for five years from 2019 to 2023.
RCVS Examinations Manager, Victoria Hedges, said: "The review of the Statutory Membership Examination has provided us with the opportunity to ensure that we continue to test the skills and knowledge needed to work effectively in a veterinary practice in the UK in a robust manner, and bring it in line with the final year examinations delivered at UK vet schools. In designing the examination, the RCVS has considered international best practice, in addition to approaches to regulatory examinations within both the veterinary and medical sectors."
A comprehensive handbook regarding this new examination will be available on the Statutory Membership Examination section of the RCVS website (www.rcvs.org.uk/statutory-membership-exam) shortly.
If you have any questions, please get in contact with Examinations Manager, Victoria Hedges: v.hedges@rcvs.org.uk
Hysolv says the vaccine, which was developed by IDT Biologika, has been used successfully in Germany, where 1.7 million doses have been prescribed. The company says field trials have shown that vaccination not only protected against clinical signs of influenza but also resulted in improvements in reproduction and piglet performance.
Two 1 ml doses of the inactivated vaccine can be injected intramuscularly three weeks apart to pigs from 56 days old, providing immunisation to the majority of animals within seven days.
Hysolv director, Geoff Hooper said: "Swine flu can be devastating to a herd and this vaccine will broaden protection, particularly when used with our existing vaccine Respiporc FLU3, which we are strongly advising."
Respiporc FLU3 protects against three other strains of swine flu (H1N1, H1N2 and H3N2). Hysolv says that when used together, the two vaccines protect pigs against the most relevant strains in the British Isles.
Geoff added: "There have been several flu pandemics throughout the years – the latest in 2009. It is not possible to predict the emergence of a pandemic strain accurately but this vaccine combined with Respiporc FLU3 will greatly decrease the chance of pigs becoming infected."
In case you need any reminding, acepromazine belongs to the phenothiazine family and acts as a dopamine receptor antagonist, providing calming effects1, 2. It causes sedation and anxiolysis, which is initially dose dependent, plateauing at higher doses1, 3. It is metabolised in the liver and has a long duration of action of approximately six hours in healthy patients1.
For best results AceSedate should be combined with an opioid (neuroleptanalgesia) to improve the quality and reliability of sedation and provide analgesia1, 2, 3.
Richard Beckwith, country manager of Jurox (UK) Ltd said: "AceSedate is a welcome addition to our analgesia and anaesthesia range providing our customers with a high-quality product at an economical price."
For further information, visit www.jurox.com/uk, contact your Jurox technical sales rep, ring the customer services team on 0800 500 3171 or e-mail: info@jurox.co.uk.
References
Bravecto Plus contains fluralaner (280 mg/ml), an ectoparasiticide which provides systemic activity against ticks (lxodes ricinus) and fleas (Ctenocephalides felis), and moxidectin (14 mg/ml), an endoparasiticide which provides systemic activity against a range of internal worms, including heartworm (Dirofilaria immitis), intestinal roundworm and hookworm.
Bravecto Plus is applied topically using the "Twist'n'Use" pipette. Once applied, the product kills ticks and fleas for 12 weeks, while also treating intestinal roundworm and hookworm and preventing heartworm disease for eight weeks.
Bravecto Plus can also be used as part of a treatment strategy for flea allergy dermatitis.
Bravecto was first launched in 2014 as a chewable tablet for dogs. In 2016 Bravecto spot-on was launched as a topical solution for dogs and cats. More than 80 million doses of Bravecto have been sold in 72 countries since 2014.
Amanda Melvin, marketing manager, at MSD Animal Health, said: "We are pleased to introduce the latest innovation in feline parasite protection to the Bravecto family."
For more information, refer to the summary of product characteristics or contact your MSD account manager.
According to the company, two promotional videos it prepared for social media have already reached more than 1.7 million people in the first two days of the campaign.
Virbac says that some of the UK's best loved pet influencers will also be promoting the campaign to their followers over the coming week.
What is a pet influencer, anyway? Someone who influences pets? I picture a Barbara-Woodhouse sort of character surrounded by a rapt audience of dogs: "Come on now, dogs, eat Veterinary HPM, it really is properly yummy, and sooo good for you."
I digress.
As part of the campaign pet owners will be able use an online protein calculator to check whether their current pet food is providing optimal levels of protein to their pet.
Pet owners will also be able to locate their nearest veterinary practice stockist using a new locator tool on the Virbac website and benefit from a discount voucher for their first Veterinary HPM purchase, which can only be redeemed in participating veterinary practices.
Tracey West, Nutrition Manager at Virbac, said: "Nutrition plays such a key role in the long-term health and well-being of our pets, and veterinary practices play such a key role in educating pet owners on this important subject.
"We’re delighted that as part of our ‘pro-veterinary’ strategy for Veterinary HPM, we will be able to help drive pet owners back into veterinary practices with this campaign."
For more information, speak to your Virbac Territory Manager.
IVC was formed in 2011, the result of a merger of several independent veterinary hospitals. Under the leadership of David Hillier, and with backing from Summit Partners in 2014, it grew to over 300 practices before being acquired by the Swedish EQT Partners in January 2017.
In August last year the company merged with Evidensia Group, another veterinary corporate group with practices around Europe, bringing the total to more than 850 clinics and hospitals in eight countries.
EQT has reportedly now instructed Jefferies Investment Bank to auction the business in the first week of November.
No word yet on where the auction will take place. If you go, be careful not to scratch your nose at the wrong moment ("1.7 billion from the gentleman at the back. Yes, that's YOU, Sir.").
Mark, who graduated from Cambridge University in 1997, has a broad interest in internal medicine but particularly enjoys the challenges posed by gastrointestinal, endocrine, haematology and renal medicine.
He has a PhD in Neuroscience at the University of Cambridge and after completing his PhD he took a residency in Small Animal Medicine at Cambridge, followed by four years in a private specialist practice in the south of England.
Mark was then appointed Clinical Associate Professor in Small Animal Internal Medicine at the Nottingham Veterinary School, where he was responsible for running the final year medicine rotation along with lecturing to all years of the veterinary course.
He was also in charge of the school’s small animal intern and residency programmes in addition to supervising both undergraduate and post-graduate research students.
Mark has also been involved in national and international investigations into canine breed-related diseases such as canine cancer, canine and feline haematology, canine endocrine disease and the development of novel non-invasive biomarkers to help diagnose both simple and complex medical diseases.
Outside work, Mark is a seven-guitar-owning-musician, a race-winning cyclist and a keen runner with a personal best of one hour twenty five minutes for a half marathon. What a relief for the rest of us mere mortals to hear there's something he's rubbish at: he says he swims 'like a brick'.
Mark said: "I’m excited to be joining the outstanding team at Willows who deliver such exceptional care to pets and their owners and such an outstanding service to the referring veterinary surgeons.
"It is a wonderful opportunity for me and I’m really looking forward to making my own contribution to their continued success."
The Lintbells Mobility Matters initiative provides materials designed to help improve communication and client understanding of their pet’s condition. It includes a guide on how to set up a mobility-focused nurse-led clinic, together with a step-by-step guide in a flip chart format to help RVNs recommend dietary supplements or modifications.
To help launch the clinic, Lintbells Veterinary Business Development Executives can provide lunch and learn sessions. Practices can also become approved Mobility Matters practices with certified CPD for the whole team to ensure that the process of recommendation and referral to the clinic occurs seamlessly and involves everyone in the practice.
Yumove Brand Manager Gemma Cunningham said: "Feedback about the pack is that it helps vets and vet nurses explain mobility problems to owners in a simple but structured way to improve buy-in to a multimodal approach".
Practices that want to register an interest in the initiative can contact their local Lintbells Veterinary Business Development Executive or visit www.lintbellsvet.com.
The association says the qualification will help vets conduct clinical research relating to their work - in particular vets working in practice. It is aimed at people who already have any accredited postgraduate certificate (60 credits at Level 7) relevant to some aspect of veterinary medicine or surgery and are keen to develop a deeper understanding of their research topic.
The Masters starts with online study into the principles of clinical research, which students then apply to their own research project, based on a further 1,200 study hours that could be flexibly achieved in two years of part-time study or up to five years, depending on the project type and an individual’s availability.
Lucie Goodwin, BSAVA Head of Education (pictured right), said: "For those vets who have already completed a postgraduate certificate it is an opportunity to develop their skills further, partake in research and collect valuable data from the field. So much of the published data in veterinary journals is based upon a referral population and this may not necessarily reflect what truly happens in clinical practice."
She added: "The BSAVA Masters is designed to appeal to vets who want to undertake research alongside their job role, without having to commit to a full-time programme of study."
Students will be allocated a ‘matched’ supervisor to provide project advice and guidance, plus the BSAVA team will be on hand to ensure ongoing support and encouragement.
Johanna Forsyth, senior veterinary technical manager with the diagnostic laboratory Avacta Animal Health, joined the Masters programme when it launched in 2016. She said: "The thing that has given me the most satisfaction from taking part in this programme is the way my views have changed. I look at things I wrote a little while back and think: 'Did I really say that?'. You become so absorbed in the project that you don’t notice how your understanding of the topic has grown. It’s so subtle, we haven’t been force-fed anything - it’s just like osmosis."
For more information, please contact masters@bsava.com or visit the website https://www.bsava.com/Education/Masters
The case studies were developed by the RCVS Standards Committee and use a variety of examples of where miscommunication between a client and the veterinary practice can lead to an inadequate level of consent being gained for procedures and treatment, including euthanasia.
Examples include damaged teeth being removed during a clean and polish dental procedure without the owner’s express permission and not giving the full range of options available in the case of a dog with an osteosarcoma.
The case studies follow the Standards Committee approving changes to chapter 11 (‘Communication and consent’) of the supporting guidance to the RCVS Code of Professional Conduct in January 2018 to give further advice on how to discuss informed consent with clients, who can be responsible for gaining consent for a procedure and additional guidance on consent forms.
Dr Kate Richards MRCVS, Chair of the RCVS Standards Committee, said: "We hope these case studies will prove useful to practitioners who are having to deal with the complexities around making sure that procedures are fully explained to ensure informed consent is gained.
"We understand the difficulties that are encountered and so these case studies, based on real-life scenarios, highlight where things may go wrong and how these incidents can be avoided by being thorough and ensuring that good communication is at the heart of all we do."
To view the case studies, visit www.rcvs.org.uk/informed-consent.
Chapter 11 of the RCVS supporting guidance on communication and consent is available to view at www.rcvs.org.uk/consent
The course is aimed at veterinary professionals across Europe who want to advance their knowledge and diagnostic skills, progress their academic qualifications and gain recognition in their field.
The GPAdvCert in Small Animal Medicine is for veterinary surgeons who have already completed a General Practitioner Certificate in Small Animal Medicine (GPCertSAM) or a Postgraduate Certificate (PgC) in Small Animal Medicine.
Accredited by the European School of Veterinary Postgraduate Studies (ESVPS) and validated by Harper Adams University, the programme will be delivered in three, five-day blocks of training by globally recognised experts in three European training centres - Sheffield, UK; Porto, Portugal and Berlin, Germany. The programme includes a practical session in which delegates will perform an upper and lower gastrointestinal endoscopy under the guidance of their tutor.
David Babington MRCVS, Business Development Director of Improve International (pictured right), said: "Delegates attending our first GPAdvCert in Small Animal Medicine will enhance their skills and confidence in dealing with complex animal medicine cases. Each module will take their knowledge beyond Postgraduate Certificate level with more in-depth and advanced content covering topics as diverse as mycobacterial and ureteric disease. They will also learn how to design a detailed diagnostic plan and build an understanding of nuances in interpreting laboratory findings to enable them to manage cases requiring complex therapeutic management with confidence."
He added: "The qualification is a natural ‘next-step’ for veterinary surgeons wanting to further progress their knowledge of small animal internal medicine. It will help them to reduce the number of patients which are referred, retaining a higher level of income for their practice and will also provide them with skills which they can pass onto their team."
Improve says the successful achievement of the GPAdvCert will enable delegates to progress from a Postgraduate Certificate in Small Animal Medicine (or equivalent) to the Postgraduate Diploma in Advanced Veterinary Practice Sciences in the UK, which is awarded by Harper Adams University. This can, in turn, be used towards the award of a Masters Degree (MSc) in Advanced Veterinary Practice Sciences.
The VCMS, which is administered by Nockolds Solicitors, was formally launched by the RCVS as an alternative dispute resolution service in October 2017 following a year-long trial.
The aim of the service is to resolve, by mediation, disputes between clients and veterinary practices that do not meet the threshold of serious professional misconduct that is needed for the RCVS to investigate a concern through its formal processes.
Since the service’s trial, which started in October 2016, the VCMS has given preliminary mediation advice on how to resolve a case in more than 1,700 instances with over 580 cases having gone to full mediation of which 89% have concluded with a resolution.
Eleanor Ferguson, RCVS Registrar and Director of Legal Services, said: "From the perspective of both the public and the profession, the establishment of the VCMS has been a "win-win" situation. For the public it has provided them with an additional route to solve those complaints which wouldn’t cross the threshold to progress in the concerns investigation process.
"For the profession it has provided a more appropriate format for resolving a client dispute that doesn’t involve the time, effort and formal process of an RCVS investigation for those cases that will never amount to serious professional misconduct. I think this has been demonstrated by the fact that the vast majority of the profession are willing to engage with the VCMS process, even though it is entirely voluntary.
"The VCMS has also had a positive impact on the College and its concerns investigation process, allowing us to focus greater resources on those cases that do meet our threshold of serious professional misconduct. This has had a very clear impact on the speed with which we either close cases or move them on to the next stage of consideration by the Preliminary Investigation Committee (PIC), which, again, is important to both the public and the profession."
The College says that around 90% of cases investigated at Stage 1 of the process are now either closed or referred to PIC within four months – the College’s key performance indicator at this stage. This compares to around 50% of these cases being closed or referred within four months at Stage 1 in 2016.
The College also says that in total (including both preliminary and full mediation cases), 86% of the cases dealt with by VCMS were successfully mediated and feedback from both clients and veterinary practices has been largely positive. In client feedback from the third quarter of 2018, 93% said they would use the VCMS again and 79% considered it to be fair, while the equivalent figure amongst veterinary practices was 94% and 87% respectively.
Jennie Jones, a partner at Nockolds Solicitors who heads up the VCMS, said: "It is a good sign that mediation is largely working as it should when both parties are reporting similar satisfaction rates and we pride ourselves on negotiating resolutions that are acceptable and beneficial for both the clients and the practices.
"It is great to see that our efforts are also having an impact on the RCVS concerns investigation system by allowing it to concentrate on more serious cases."
More information about the RCVS concerns investigation process, including the different stages of an investigation, can be found at www.rcvs.org.uk/concerns
Further information about the VCMS can be found on its website at www.vetmediation.co.uk or by calling 0345 040 5834.
The course will be led by Dr Jon Hall, a European Specialist in Small Animal Surgery and Dr Danielle Gunn-Moore, an RCVS-recognised Specialist in Feline Medicine, supported by RVN Ms Claire Dorey-Phillips. It will take place at Improve’s new practical training facility in Sheffield in January 2019.
Improve says the programme will equip delegates with a full understanding of the causes of FLUTD and help them to advise owners with cats suffering from the condition in order to improve long-term outcomes. It will also provide a comprehensive overview of the nursing and medical options to treat feline idiopathic cystitis (FIC) and other causes of FLUTD including infection, calculi and neoplasia. The range of appropriate surgical methods to treat ureteral obstructions will also be covered, along with the post-operative nursing care, to ensure that delegates feel ready to perform a variety of bladder surgeries with confidence.
Juliet Pope MRCVS, Veterinary Operations Manager at Improve International (pictured right), said: "Treating patients with FLUTD is a team effort so we’re offering a special rate for a vet and nurse attending from the same practice though both vets and nurses can still, of course, book independently. The cutting-edge programme will be highly interactive and we aim to send delegates back to their practices with a revitalised approach to these tricky cat cases."
For further information visit www.improveinternational.com or email enquiries@improveinternational.com or call 01793 759159.
EthyCalm is sprayed directly on the skin, or, for more fractious patients, can be applied with a swab.
Invicta says that unlike other products the effect is instant and EthyCalm leaves no residue on the skin surface.
The improved product, EthyCalm Plus, contains 50% more product (good for over 100 applications) and incorporates a new 'on-off' switch for easier application. It is also now packed in a 'no-roll' case to protect from damage.
Rob Watkins, Managing Director of Invicta, said: "EthyCalm has been an incredibly popular product with nurses and vets. As a small company we always listen to our customers and have taken the opportunity to incorporate suggestions for improvement. The result is EthyCalm Plus which offers significant enhancement over the original product".
EthyCalm Plus is available from veterinary wholesalers and for a limited time the price has been held at £25 each.